This has led to drug approval being sought under the Food and Drug Administration's subpart H pathway in the United States, in which short-term improvement in histology, based on the mechanism of action of a drug, allows conditional approval with the requirement that additional studies are undertaken to demonstrate that short-term changes translate into reduced progression to cirrhosis and its complications
Mosaffa-Jahromi M, Lankarani KB, Pasalar M, Afsharypuor S, Tamaddon A-M
Get tips, advice, and encouragement Connect with our community to share your journey and stay motivated
thats why this category may become bigger than just weight loss drugs we maybe be entering an era of : metabolic medicine
[PubMed: 16822820] 238
This comes as no surprise, as the meds help many people achieve significant weight loss and lower blood sugar levels